quantisnow
FeedTopReportsPricing
⌘K
Live feed
17:32:06·605d
INSIDERFiling
Agile Therapeutics Inc. logo

Director Fischer Seth H. Z. returned $1,484 worth of shares to the company (976 units at $1.52), closing all direct ownership in the company (SEC Form 4)

AGRX· Agile Therapeutics Inc.
Health Care
Original source

Companies

  • AGRX
    Agile Therapeutics Inc.
    Health Care

Recent analyst ratings

  • Nov 3UpdateHC Wainwright & Co.$2.50
  • Sep 13UpdateHC Wainwright & Co.$3.50
  • Jul 27UpdateRBC Capital$5.00

Related

  • SEC604d
    SEC Form RW filed by Agile Therapeutics Inc.
  • SEC604d
    SEC Form EFFECT filed by Agile Therapeutics Inc.
  • SEC604d
    SEC Form EFFECT filed by Agile Therapeutics Inc.
  • SEC604d
    SEC Form EFFECT filed by Agile Therapeutics Inc.
  • INSIDER605d
    Chief Administrative Officer Gilmore Geoffrey returned $30,789 worth of shares to the company (20,256 units at $1.52), closing all direct ownership in the company (SEC Form 4)
  • INSIDER605d
    Chief Financial Officer Coiante Scott M returned $30,522 worth of shares to the company (20,080 units at $1.52), closing all direct ownership in the company (SEC Form 4)
  • INSIDER605d
    Chief Supply Chain Officer Conway Robert G returned $20,564 worth of shares to the company (13,529 units at $1.52), closing all direct ownership in the company (SEC Form 4)
  • INSIDER605d
    Chief Medical Officer Korner Paul returned $20,520 worth of shares to the company (13,500 units at $1.52), closing all direct ownership in the company (SEC Form 4)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022